Evidence map›Paper›PMID 36765944›Full record

ArticleCancers2023

Lower Expression of

Patricia Scott, Shuo Wang, Guillaume Onyeaghala, Nathan Pankratz, Timothy Starr, Anna E Prizment

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patricia ScottDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN 55812, USA.
Shuo WangDivision of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN 55455, USA.ORCID 0000-0003-4627-8625
Guillaume OnyeaghalaDivision of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN 55455, USA.ORCID 0000-0001-8090-5640
Nathan PankratzDepartment of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Timothy StarrDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota Medical School, Minneapolis, MN 55455, USA.ORCID 0000-0002-6308-3451
Anna E PrizmentDivision of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, MN 55455, USA.ORCID 0000-0001-5924-6871

Funding

Role of genetic and epigenetic alterations in CFTR in colorectal cancerR21CA256749 · NCI · UNIVERSITY OF MINNESOTA · PI PRIZMENT, ANNA, SCOTT, PATRICIA M · 2021 to 2022
$406k
NCI NIH HHS R21 CA256749NIH HHS 1R21 1CA256749-01A1University of Minnesota, Academic Health Center Faculty Research Development GrantWhiteside Institute for Clinical Research Research Grant
6 · The paper itself

Abstract

Individuals with cystic fibrosis (CF), caused by biallelic germline mutations in the cystic fibrosis transmembrane conductance regulator (

Indexed as

CFTRcolorectal cancerCox proportional hazards regressionmortalitysurvivalTCGA COADREAD

Identifiers

PMID36765944
PMCPMC9913301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.